AUD Daily Review for January 8, 2018
|Audentes Therapeutics Inc. (BOLD) announced positive interim results from the first dose cohort of its Phase 1/2 clinical trial of AT132 Thursday morning. Audentes Therapeutics rose sharply during the first half hour of trade Thursday, but settled into a range for the rest of the session.|
|The US dollar has rallied against the Japanese yen on Friday, which of course is significant considering that the jobs market number missed completely. I thi…|
|Large speculators build largest net-long on record in the Euro-FX contract, while selling the Australian dollar aggressively as it rises.|
Have a nice trading!